An important role for syndecan-1 in herpes simplex virus type-1 induced cell-to-cell fusion and virus spread

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Karasneh, Ghadah A ^a   Ali, Mohamed ^a   Shukla, Deepak ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; SYNDECAN 1; VIRUS FUSION PROTEIN;

ANIMAL CELL; ARTICLE; CELL FUSION; CELL LINE; CELL SURFACE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MEMBRANE FUSION; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; VIRUS TRANSMISSION; ANIMAL; CELL NUCLEUS; CHEMISTRY; CHO CELL; CORNEA EPITHELIUM; CRICETULUS; CYTOLOGY; CYTOPLASM; DOWN REGULATION; GENE SILENCING; GENETICS; GIANT CELL; GROWTH, DEVELOPMENT AND AGING; HAMSTER; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; VIROLOGY; VIRUS CULTURE; VIRUS ENTRY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1;

ANIMALS; CELL NUCLEUS; CHO CELLS; CRICETINAE; CRICETULUS; CYTOPLASM; DOWN-REGULATION; EPITHELIUM, CORNEAL; GENE KNOCKDOWN TECHNIQUES; GIANT CELLS; HERPESVIRUS 1, HUMAN; HUMANS; MUTATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SYNDECAN-1; VIRAL FUSION PROTEINS; VIRAL PLAQUE ASSAY; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 80052989474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025252     Document Type: Article

References (59)

1. Wilhelmus K, Beck R, Moke P, Dawson C, Barron B, et al. (1998) Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 339: 300-306.
2. Loutsch JM, Perng GC, Hill JM, Zheng X, Marquart ME, et al. (1999) Identical 371-base-pair deletion mutations in the LAT genes of herpes simplex virus type 1 McKrae and 17syn+ result in different in vivo reactivation phenotypes. J Virol 73: 767-771.
3. Schleiss MR, (2009) Persistent and recurring viral infections: the human herpesviruses. Curr Probl Pediatr Adolesc Health Care 39 (1): 7-23.
4. Eizuru Y, (2003) Development of new antivirals for herpesviruses. Antivir Chem Chemother 14 (6): 299-308.
5. Shukla D, Spear PG, (2001) Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest 108 (4): 503-510.
6. Clement C, Tiwari V, Scanlan PM, Valyi-Nagy T, Yue BY, et al. (2006) A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol 174 (7): 1009-1021.
7. Heldwein EE, Krummenacher C, (2008) Entry of herpesviruses into mammalian cells. Cell Mol Life Sci 65 (11): 1653-1668.
8. O'Donnell CD, Shukla D, (2008) The Importance of Heparan Sulfate in Herpesvirus Infection. Virol Sin 23: 383-393.
9. Herold BC, Visalli RJ, Sumarski N, Brandt C, Spear PG, (1994) Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparin sulfate and glycoprotein B. J. Gen. Virol. 75: 1211-1222.
10. Bacsa S, Karasneh G, Dosa S, Liu J, Valyi-Nagy T, et al. (2010) Syndecan-1 and syndecan-2 play key roles in herpes simplex virus type 1 infection. J Gen Virol 92 (Pt 4): 733-743.
11. Cheshenko N, Liu W, Satlin LM, Herold BC, (2007) Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry. Mol Biol Cell 18: 3119-3130.
12. WuDunn D, Spear PG, (1989) Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 63: 52-58.
13. Herold BC, WuDunn D, Soltys N, Spear PG, (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 65: 1090-1098.
14. Akhtar J, Shukla D, (2009) Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J 276: 7228-7236.
15. Montgomery RI, Warner MS, Lum BJ, Spear PG, (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427-436.
16. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, et al. (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99: 13-22.
17. Satoh T, Arii J, Suenaga T, Wang J, Kogure A, et al. (2008) PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132 (6): 935-944.
18. Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, et al. (2010) Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 467 (7317): 859-862.
19. Scanlan PM, Tiwari V, Bommireddy S, Shukla D, (2003) Cellular expression of gH confers resistance to herpes simplex virus type-1 entry. Virology 312: 14-24.
20. Multhaupt HA, Yoneda A, Whiteford JR, Oh ES, Lee W, et al. (2009) Syndecan signaling: when, where and why? J Physiol Pharmacol 60 (Suppl 4): 31-38.
21. Muto T, Miyoshi K, Munesue S, Nakada H, Okayama M, et al. (2007) Differential expression of syndecan isoforms during mouse incisor amelogenesis. J Med Invest 54 (3-4): 331-339.
22. Schofield KP, Gallagher JT, David G, (1999) Expression of proteoglycan core proteins in human bone marrow stroma. Biochem J 343 (Pt 3): 663-668.
23. Tumova S, Woods A, Couchman JR, (2000) Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int J Biochem Cell Biol 32 (3): 269-288.
24. Couchman JR, (2003) Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol; 4 (12): 926-937.
25. Tkachenko E, Rhodes JM, Simons M, (2005) Syndecans: new kids on the signaling block. Circ Res 96 (5): 488-500.
26. O'Donnell CD, Shukla D, (2009) A novel function of heparan sulfate in the regulation of cell-cell fusion. J Biol Chem 284 (43): 29654-29665.
27. Filla MS, David G, Weinreb RN, Kaufman PL, Peters DM, (2004) Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp Eye Res 79 (1): 61-74.
28. Farooq AV, Shukla D, (2011) Corneal latency and transmission of herpes simplex virus-1. Future Virol 6: 101-108.
29. Shah A, Farooq AV, Tiwari V, Kim MJ, Shukla D, (2010) HSV-1 infection of human corneal epithelial cells: receptor-mediated entry and trends of re-infection. Mol Vis 16: 2476-2486.
30. Pertel PE, Fridberg A, Parish ML, Spear PG, (2001) Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology 279 (1): 313-324.
31. Esko JD, Rostand KS, Weinke JL, (1988) Tumor formation dependent on proteoglycan biosynthesis. Science 241 (4869): 1092-1096.
32. Hu C, Ahmed M, Melia TJ, Söllner TH, Mayer T, et al. (2003) Fusion of cells by flipped SNAREs. Science 300: 1745-1749.
33. McQuade KJ, Beauvais DM, Burbach BJ, Rapraeger AC, (2006) Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts. J Cell Sci 119 (Pt 12): 2445-2456.
34. Zhe R, Mei-Ying Z, Kitazato K, Kobayash N, Qin-Chang Z, et al. (2008) Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA. Arch Virol 153 (7): 1401-1406.
35. Desai P, Person S, (1998) Incorporation of the green fluorescent protein into the herpes simplex virus type 1 Capsid. J Virol 72 (9): 7563-7568.
36. Geraghty RJ, Jogger CR, Spear PG, (2000) Cellular expression of alphaherpesvirus gD interferes with entry of homologous and heterologous alphaherpesviruses by blocking access to a shared gD receptor. Virology 268: 147-158.
37. Couchman JR, (2010) Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol 26: 89-114.
38. Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC, (2009) Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med 206 (3): 691-705.
39. Gianni T, Gatta V, Campadelli-Fiume G, (2010) {alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2. Proc Natl Acad Sci U S A 107 (51): 22260-22265.
40. Carey DJ, Stahl RC, Cizmeci-Smith G, Asundi VK, (1994) Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading. J Cell Biol 124 (1-2): 161-170.
41. Beauvais DM, Rapraeger AC, (2004) Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2: 3.
42. Xian X, Gopal S, Couchman JR, (2010) Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res 339 (1): 31-46.
43. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, al et, (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777.
44. Zong F, Fthenou E, Castro J, Péterfia B, Kovalszky I, et al. (2010) Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains. Cell Prolif 43 (1): 29-40.
45. Oh JH, Lee HS, Park SH, Ryu HS, Min CK, (2010) Syndecan-1 overexpression promotes tumor growth and angiogenesis in an endometrial cancer xenograft model. Int J Gynecol Cancer 20 (5): 751-756.
46. Oh MJ, Akhtar J, Desai P, Shukla D, (2010) A role for heparan sulfate in viral surfing. Biochem Biophys Res Commun 391 (1): 176-181.
47. Zhou Y, Guo YJ, Liu X, Mei YW, (2009) Cell cycle inhibitor enhances the resolution of HSV-1-induced proinflammatory response in murine microglial cells. Neurol Res 31 (9): 910-916.
48. Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT, (2001) Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 75 (20): 9828-9835.
49. Carbone A, Gaidano G, Gloghini A, Larocca LM, Capello D, (1998) Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 91 (3): 747-755.
50. Gaidano G, Gloghini A, Gattei V, Rossi MF, Cilia AM, et al. (1997) Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood 90: 4894-4900.
51. Shafti-Keramat S, Handisurya A, Kriehuber E, Meneguzzi G, Slupetzky K, (2003) Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol 77 (24): 13125-13135.
52. Bobardt MD, Saphire AC, Hung HC, Yu X, Van der Schueren B, et al. (2003) Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity. 18 (1): 27-39.
53. Araki-Sasaki K, Ohashi Y, Sasabe T, Hayashi K, Watanabe H, et al. (1995) An SV40-immortalized human corneal epithelial cell and its characterization. Invest Ophthalmol Vis Sci 36: 614-621.
54. Pertel PE, Spear PG, (1997) Partial resistance to gD-mediated interference conferred by mutations affecting herpes simplex virus type 1 gC and gK. J Virol 71 (10): 8024-8028.
55. McQuade KJ, Rapraeger AC, (2003) Syndecan-1 transmembrane and extracellular domains have unique and distinct roles in cell spreading. J Biol Chem 278 (47): 46607-46615.
56. Shukla SY, Singh YK, Shukla D, (2009) Role of nectin-1, HVEM, and PILR-alpha in HSV-2 entry into human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 50 (6): 2878-2887.
57. Tiwari V, Clement C, Duncan MB, Chen J, Liu J, et al. (2004) A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1. J Gen Virol 85: 805-809.
58. Roller RJ, Herold BC, (1997) Characterization of a BHK(TK-) cell clone resistant to postattachment entry by herpes simplex virus types 1 and 2. J Virol. 71 (8): 5805-5813.
59. Tiwari V, Liu J, Valyi-Nagy T, Shukla D, (2011) Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J Biol Chem 286: 25406-25415.